| Brown Cty Comm Treatment Ctr-bayshore Village | |
| 3150 Gershwin Drive, Green Bay, Wisconsin 54311 | |
| (920) 391-4700 | |
| Name | Brown Cty Comm Treatment Ctr-bayshore Village |
|---|---|
| Location | 3150 Gershwin Drive, Green Bay, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 63 |
| Occupancy Rate | 89.84% |
| Medicare ID (CCN) | 525693 |
| Legal Business Name | County Of Brown |
| Ownership Type | Government - County |
| NPI Number | 1033214150 |
| Organization Name | COUNTY OF BROWN |
| Doing Business As | BROWN COUNTY COMMUNITY TREATMENT CENTER-BAYSHORE VILLAGE |
| Address | 3150 Gershwin Drive, Green Bay, WI 54311 |
| Phone Number | 920-391-4700 |
News Archive
GTx, Inc. today presented additional results from the Ostarine™ Phase IIb study demonstrating an improvement in quality of life (fatigue and anorexia) in cancer patients with muscle wasting (cancer cachexia) who demonstrated improvement in functional performance as measured by stair climb. Ostarine (GTx-024) is GTx's lead selective androgen receptor modulator (SARM) which the company is developing for the treatment of cancer cachexia.
Scientists at the Center for Translational Medicine at the Temple University School of Medicine are inching closer to solving a long-standing mystery in sepsis, a complex and often life-threatening condition that affects more than 400,000 people in the U.S. every year.
Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, today announces that Western Maryland Regional Medical Center's recent upgrade to the newest version of IMPAX HeartStation ECG Management System has helped enable the rapid diagnosis and treatment of patients with posterior wall heart attacks. The Cumberland-based hospital is using the recently released features of IMPAX HeartStation to digitally review and archive 15-lead ECG studies.
Exactly one year after the approval of the Environmental Impact Report and Specific Plan by the March Joint Powers Authority, March HealthCare Development, LLC (MHD) has signed an agreement with the Riverside Medical Clinic (RMC) that will be the foundation for a new integrated healthcare delivery system on the March LifeCare campus.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
GTx, Inc. today presented additional results from the Ostarine™ Phase IIb study demonstrating an improvement in quality of life (fatigue and anorexia) in cancer patients with muscle wasting (cancer cachexia) who demonstrated improvement in functional performance as measured by stair climb. Ostarine (GTx-024) is GTx's lead selective androgen receptor modulator (SARM) which the company is developing for the treatment of cancer cachexia.
Scientists at the Center for Translational Medicine at the Temple University School of Medicine are inching closer to solving a long-standing mystery in sepsis, a complex and often life-threatening condition that affects more than 400,000 people in the U.S. every year.
Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, today announces that Western Maryland Regional Medical Center's recent upgrade to the newest version of IMPAX HeartStation ECG Management System has helped enable the rapid diagnosis and treatment of patients with posterior wall heart attacks. The Cumberland-based hospital is using the recently released features of IMPAX HeartStation to digitally review and archive 15-lead ECG studies.
Exactly one year after the approval of the Environmental Impact Report and Specific Plan by the March Joint Powers Authority, March HealthCare Development, LLC (MHD) has signed an agreement with the Riverside Medical Clinic (RMC) that will be the foundation for a new integrated healthcare delivery system on the March LifeCare campus.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $975 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.62 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.21 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.19 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.92 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.9 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 1.32 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.64 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.56 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 34.23 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 61.54 | 83.88 |